Patents by Inventor Jennifer J. Archer

Jennifer J. Archer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12234135
    Abstract: A fire apparatus includes a chassis, a front axle coupled to the chassis, a rear axle coupled to the chassis, a torque box coupled to the chassis, a pedestal coupled to the torque box, a ladder assembly coupled to the pedestal, and a stability assembly. The torque box has a front end and a rear end. The pedestal is positioned between the front end and the rear end of the torque box. The stability assembly includes a housing coupled to the chassis and the front end of the torque box, a pair of outriggers received within the housing, and a downrigger coupled to the rear end of the torque box. The pair of outriggers is selectively extendable laterally outward in opposing directions. The downrigger is selectively extendable downward.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: February 25, 2025
    Assignee: Oshkosh Corporation
    Inventors: David W. Archer, Don Parshall, Eric D. Betz, Eric R. Linsmeier, Jennifer L. Bloemer, Jeffrey D. Aiken, Jon J. Morrow, Michael R. Moore, Peter K. Kramer, Troy D. Lind
  • Patent number: 9730902
    Abstract: Novel polyamine transport inhibitors have been synthesized and demonstrated to block the uptake of native polyamines into human cancer cells. A combination therapy of the transport inhibitor and DFMO (a drug which blocks polyamine biosynthesis) provided synergistic activity against a metastatic human colon cancer cell line. The strategy uses polyamine depletion and polyamine metabolism to generate reactive oxygen species within cells as a novel way to treat cancers. This approach may be implemented for widespread use in the treatment of diseases which rely upon polyamine transport activity for proliferation.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: August 15, 2017
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Otto Phanstiel, IV, Jennifer J. Archer
  • Publication number: 20160151312
    Abstract: Novel polyamine transport inhibitors have been synthesized and demonstrated to block the uptake of native polyamines into human cancer cells. A combination therapy of the transport inhibitor and DFMO (a drug which blocks polyamine biosynthesis) provided synergistic activity against a metastatic human colon cancer cell line. The strategy uses polyamine depletion and polyamine metabolism to generate reactive oxygen species within cells as a novel way to treat cancers. This approach may be implemented for widespread use in the treatment of diseases which rely upon polyamine transport activity for proliferation.
    Type: Application
    Filed: December 8, 2015
    Publication date: June 2, 2016
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Otto PHANSTIEL, IV, Jennifer J. ARCHER
  • Patent number: 9212131
    Abstract: Novel polyamine transport inhibitors have been synthesized and demonstrated to block the uptake of native polyamines into human cancer cells. A combination therapy of the transport inhibitor and DFMO (a drug which blocks polyamine biosynthesis) provided synergistic activity against a metastatic human colon cancer cell line. The strategy uses polyamine depletion and polyamine metabolism to generate reactive oxygen species within cells as a novel way to treat cancers. This approach may be implemented for widespread use in the treatment of diseases which rely upon polyamine transport activity for proliferation.
    Type: Grant
    Filed: June 21, 2010
    Date of Patent: December 15, 2015
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Otto Phanstiel, Jennifer J. Archer
  • Publication number: 20120172449
    Abstract: Novel polyamine transport inhibitors have been synthesized and demonstrated to block the uptake of native polyamines into human cancer cells. A combination therapy of the transport inhibitor and DFMO (a drug which blocks polyamine biosynthesis) provided synergistic activity against a metastatic human colon cancer cell line. The strategy uses polyamine depletion and polyamine metabolism to generate reactive oxygen species within cells as a novel way to treat cancers. This approach may be implemented for widespread use in the treatment of diseases which rely upon polyamine transport activity for proliferation.
    Type: Application
    Filed: June 21, 2010
    Publication date: July 5, 2012
    Inventors: Otto Phanstiel, Jennifer J. Archer